G1 Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
18 Sep 2024	Form 4: Secor Alicia, Director Returned 20,000 shares to the issuer · Disposed of 10,000 shares (Tender Offer) · Disposed of 90,000 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Flowers Cynthia Louise, Director Returned 20,000 shares to the issuer · Disposed of 15,889 shares (Tender Offer) · Disposed of 90,000 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Nicholson Garry A, Director Returned 20,000 shares to the issuer · Disposed of 14,389 shares (Tender Offer) · Disposed of 90,000 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Thomas Monica R., Chief Legal & People Officer Returned 138,151 shares to the issuer · Disposed of 6,674 shares (Tender Offer) · Disposed of 205,875 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Lee Jacks, Director Returned 10,000 shares to the issuer · Disposed of 10,000 shares (Tender Offer) · Disposed of 120,000 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Bailey John E. (Jack) Jr., Director Received 181,400 shares as a grant or award · Returned 534,787 shares to the issuer · Disposed of 196,287 shares (Tender Offer) · 1 more
18 Sep 2024	Form 4: Umstead John W. V, Chief Financial Officer Returned 168,387 shares to the issuer · Disposed of 19,331 shares (Tender Offer) · Disposed of 180,500 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Malik Rajesh, Chief Medical Officer Received 17,900 shares as a grant or award · Returned 89,762 shares to the issuer · Disposed of 87,450 shares (Tender Offer) · 1 more
18 Sep 2024	Form 4: Avagliano Mark, Chief Business Officer Received 20,600 shares as a grant or award · Returned 236,610 shares to the issuer · Disposed of 26,035 shares (Tender Offer) · 1 more
18 Sep 2024	Form 4: Sharpless Norman, Director Returned 20,000 shares to the issuer · Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer)
18 Sep 2024	Form 4: Murdock Terry L, Chief Operating Officer Received 17,900 shares as a grant or award · Returned 124,762 shares to the issuer · Disposed of 21,150 shares (Tender Offer) · 1 more
18 Sep 2024	Form 4: Perry Andrew, Chief Commercial Officer Received 16,100 shares as a grant or award · Returned 114,482 shares to the issuer · Disposed of 14,232 shares (Tender Offer) · 1 more
18 Sep 2024	Form 4: Muir Glenn P, Director Returned 20,000 shares to the issuer · Disposed of 185,358 shares (Tender Offer) · Disposed of 140,000 Stock Option (right to buy) (Disposition to Issuer)
08 Jul 2024	Form 4: Perry Andrew, Chief Commercial Officer Sold 1,337 shares ($3.35K)
08 Jul 2024	Form 4: Murdock Terry L, Chief Operating Officer Sold 2,475 shares ($6.21K)
08 Jul 2024	Form 4: Malik Rajesh, Chief Medical Officer Sold 2,475 shares ($6.21K)
08 Jul 2024	Form 4: Avagliano Mark, Chief Business Officer Sold 2,638 shares ($6.62K)
08 Jul 2024	Form 4: Umstead John W. V, Chief Financial Officer Sold 527 shares ($1.32K)
08 Jul 2024	Form 4: Bailey John E. (Jack) Jr., Director Sold 7,662 shares ($19.2K)
03 Jul 2024	Form 4: Perry Andrew, Chief Commercial Officer Received 35,000 shares as a grant or award

Comments